Name: CJC-1295 + Ipamorelin
SKU: 1021
Availability: InStock

This research formulation combines CJC-1295 (a tetrasubstituted GHRH analog) with Ipamorelin (a selective ghrelin receptor agonist), both of which function as growth hormone secretagogues. Together, they are studied for their potential synergistic effects on growth hormone (GH) release, cellular regeneration, and metabolic support.

CJC-1295 is noted for its extended half-life and ability to promote pulsatile GH secretion by acting on the GHRH receptor. Ipamorelin, on the other hand, mimics ghrelin’s action at the growth hormone secretagogue receptor (GHSR), further amplifying GH release without significantly impacting cortisol or prolactin levels.

Research Applications:

Preclinical studies have investigated this peptide blend for its potential in:

Stimulating endogenous growth hormone release

Supporting tissue repair and muscle recovery

Promoting lipolysis and lean body mass retention

Enhancing sleep quality and cellular regeneration

Investigating age-related GH decline models

Important Notice:

This product is intended strictly for laboratory research use only by qualified professionals. It is not for human or animal consumption, nor for therapeutic, diagnostic, or clinical applications.